| Literature DB >> 15715493 |
Gerold Hoever1, Lidia Baltina, Martin Michaelis, Rimma Kondratenko, Lia Baltina, Genrich A Tolstikov, Hans W Doerr, Jindrich Cinatl.
Abstract
Glycyrrhizin (GL) was shown to inhibit SARS-coronavirus (SARS-CoV) replication in vitro. Here the anti-SARS-CoV activity of 15 GL derivatives was tested. The introduction of 2-acetamido-beta-d-glucopyranosylamine into the glycoside chain of GL resulted in 10-fold increased anti-SARS-CoV activity compared to GL. Amides of GL and conjugates of GL with two amino acid residues and a free 30-COOH function presented up to 70-fold increased activity against SARS-CoV but also increased cytotoxicity resulting in decreased selectivity index.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15715493 DOI： 10.1021/jm0493008
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446